Cargando…
Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462782/ https://www.ncbi.nlm.nih.gov/pubmed/37650013 http://dx.doi.org/10.1016/j.jdcr.2023.06.038 |
_version_ | 1785098109309681664 |
---|---|
author | Fay, Christopher J. Moslehi, Dorsa Iriarte, Christopher Dang, Timothy M. Virgen, Cesar A. Russell-Goldman, Eleanor LeBoeuf, Nicole R. |
author_facet | Fay, Christopher J. Moslehi, Dorsa Iriarte, Christopher Dang, Timothy M. Virgen, Cesar A. Russell-Goldman, Eleanor LeBoeuf, Nicole R. |
author_sort | Fay, Christopher J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10462782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104627822023-08-30 Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib Fay, Christopher J. Moslehi, Dorsa Iriarte, Christopher Dang, Timothy M. Virgen, Cesar A. Russell-Goldman, Eleanor LeBoeuf, Nicole R. JAAD Case Rep Case Report Elsevier 2023-07-07 /pmc/articles/PMC10462782/ /pubmed/37650013 http://dx.doi.org/10.1016/j.jdcr.2023.06.038 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Fay, Christopher J. Moslehi, Dorsa Iriarte, Christopher Dang, Timothy M. Virgen, Cesar A. Russell-Goldman, Eleanor LeBoeuf, Nicole R. Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib |
title | Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib |
title_full | Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib |
title_fullStr | Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib |
title_full_unstemmed | Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib |
title_short | Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib |
title_sort | treatment-refractory cutaneous rosai–dorfman disease responsive to oral methotrexate and topical trametinib |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462782/ https://www.ncbi.nlm.nih.gov/pubmed/37650013 http://dx.doi.org/10.1016/j.jdcr.2023.06.038 |
work_keys_str_mv | AT faychristopherj treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib AT moslehidorsa treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib AT iriartechristopher treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib AT dangtimothym treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib AT virgencesara treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib AT russellgoldmaneleanor treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib AT leboeufnicoler treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib |